Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin

被引:208
作者
Buzza, MS
Zamurs, L
Sun, JR
Bird, CH
Smith, AI
Trapani, JA
Froelich, CJ
Nice, EC
Bird, PI [1 ]
机构
[1] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
[2] Melbourne Tumor Biol Branch, Ludwig Inst Canc Res, Parkville, Vic 3052, Australia
[3] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 8006, Australia
[4] Evanston NW Healthcare Res Inst, Dept Med, Evanston, IL 60201 USA
关键词
D O I
10.1074/jbc.M412001200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human granzyme B (GrB) released from cytotoxic lymphocytes plays a key role in the induction of target cell apoptosis when internalized in the presence of perforin. Here we demonstrate that GrB also possesses a potent extracellular matrix remodeling activity. Both native and recombinant GrB caused detachment of immortalized and transformed cell lines, primary endothelial cells, and chondrocytes. Cell detachment by GrB induced endothelial cell death (anoikis). GrB also inhibited tumor cell spreading, migration, and invasion in vitro. Investigation into the underlying mechanism revealed that GrB efficiently cleaves three proteins involved in extracellular matrix structure and function: vitronectin, fibronectin, and laminin. In vitronectin, GrB cleaves after an Arg-Lys-Asp (RGD) motif, which is part of the integrin-binding site found in matrix proteins. We propose that targeting of the integrin-extracellular matrix interface by GrB may allow perforin-independent killing of target cells via anoikis, restrict motility of tumor cells, facilitate lymphocyte migration, or directly reduce virus infectivity. It may also contribute to tissue destruction in diseases in which extracellular GrB is evident, such as rheumatoid arthritis and atherosclerosis.
引用
收藏
页码:23549 / 23558
页数:10
相关论文
共 96 条
[1]   Integrin α3β1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells [J].
Akula, SM ;
Pramod, NP ;
Wang, FZ ;
Chandran, B .
CELL, 2002, 108 (03) :407-419
[2]   An arthritogenic monoclonal antibody to type II collagen, CII-C1, impairs cartilage formation by cultured chondrocytes [J].
Amirahmadi, SF ;
Pho, MH ;
Gray, RE ;
Crombie, DE ;
Whittingham, SF ;
Zuasti, BB ;
Van Damme, MP ;
Rowley, MJ .
IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (04) :427-434
[3]   Fibronectin fragments and their role in inflammatory arthritis [J].
Barilla, ML ;
Carsons, SE .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2000, 29 (04) :252-265
[4]   Apoptosis of vascular smooth muscle cells in atherosclerosis [J].
Bennett, MR ;
Boyle, JJ .
ATHEROSCLEROSIS, 1998, 138 (01) :3-9
[5]   Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway [J].
Bird, CH ;
Sutton, VR ;
Sun, JR ;
Hirst, CE ;
Novak, A ;
Kumar, S ;
Trapani, JA ;
Bird, PI .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) :6387-6398
[6]   Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase [J].
Bonnefoy, A ;
Legrand, C .
THROMBOSIS RESEARCH, 2000, 98 (04) :323-332
[7]  
Browne KA, 1999, MOL CELL BIOL, V19, P8604
[8]   2 FORMS OF MURINE EPIDERMAL GROWTH-FACTOR - RAPID SEPARATION BY USING REVERSE-PHASE HPLC [J].
BURGESS, AW ;
KNESEL, J ;
SPARROW, LG ;
NICOLA, NA ;
NICE, EC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (19) :5753-5757
[9]   The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses [J].
Buzza, MS ;
Hirst, CE ;
Bird, CH ;
Hosking, P ;
McKendrick, J ;
Bird, PI .
CELLULAR IMMUNOLOGY, 2001, 210 (01) :21-29
[10]   CHARACTERIZATION OF SYNOVIAL-FLUID FIBRONECTIN FROM PATIENTS WITH RHEUMATIC INFLAMMATORY DISEASES AND HEALTHY-SUBJECTS [J].
CARNEMOLLA, B ;
CUTOLO, M ;
CASTELLANI, P ;
BALZA, E ;
RAFFANTI, S ;
ZARDI, L .
ARTHRITIS AND RHEUMATISM, 1984, 27 (08) :913-921